In conclusion, we have demonstrated that serum MMP7 levels are independently associated with clinically significant fibrosis in patients with NAFLD; and that MMP7 is a particularly strong predictor of fibrosis in patients older than 60. Here, MMP7 is linked to metabolic dysfunction-associated steatotic liver disease.